Kromek Group PLC (GB:KMK)
LSE:KMK
KMK Stock Chart & Stats
8.50 p
-0.29 p(-5.84%)
At close: 4:00 PM EST
8.50 p
-0.29 p(-5.84%)
Day’s Range― - ―
52-Week Range4.70 p - 13.00 p
Previous CloseN/A
Volume321.93K
Average Volume (3M)3.19M
Market Cap
£65.18M
Enterprise Value71.75M
Total Cash (Recent Filing)£1.25M
Total Debt (Recent Filing)£7.81M
Price to Earnings (P/E)3.6
Beta0.89
Next Earnings
Jun 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding655,096,860
10 Day Avg. Volume2,321,691
30 Day Avg. Volume3,192,291
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)0.63
Price to Sales (P/S)1.23
P/FCF Ratio2.08
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)<0.01
Revenue Forecast (FY)£27.19M
Bulls Say, Bears Say
Bulls Say
Revenue & Margin RecoveryKromek's sharp top-line recovery and materially improved margins reflect stronger product-market fit and better cost control. Sustained double-digit revenue growth with high gross margins supports durable cash generation and reinvestment capacity, improving long-term profitability resilience.
Low Leverage And Strong Equity BaseA very low debt-to-equity ratio and high equity ratio give Kromek financial flexibility to fund R&D, bid on multi-year government programs, and withstand procurement timing swings. This balance sheet strength reduces refinancing risk and supports strategic optionality over multiple quarters.
Exposure To Structural End MarketsServing government, defense, nuclear safety and medical markets ties Kromek to persistent, regulation-driven demand for radiation detection. High barriers, long program horizons, and mission-critical use create durable revenue backdrops and higher switching costs versus commodity suppliers.
Bears Say
Negative Free Cash Flow GrowthDespite operating cash covering net income (OCF/NI ~1.72), negative FCF growth signals cash conversion pressure from capex, working capital swings or program payments. If sustained, weak FCF constrains self-funded growth, dividend ability, and increases reliance on external financing.
Contract/program Timing Creates LumpinessRevenue recognition tied to contract milestones and public procurement cycles produces structural volatility. This lumpiness complicates forecasting, strains working capital in some periods, and can produce uneven cash flows that persist across multiple reporting periods.
Limited Operating Scale (small Headcount)A small workforce limits parallel program execution and manufacturing scale versus larger competitors. Limited scale can slow delivery on large government or medical contracts, raise single-program concentration risks, and constrain faster market expansion absent staffing or capital investment.
Kromek Group plc News
KMK FAQ
What was Kromek Group PLC’s price range in the past 12 months?
Kromek Group PLC lowest share price was 4.70 p and its highest was 13.00 p in the past 12 months.
What is Kromek Group PLC’s market cap?
Kromek Group PLC’s market cap is £65.18M.
When is Kromek Group PLC’s upcoming earnings report date?
Kromek Group PLC’s upcoming earnings report date is Jun 25, 2026 which is in 81 days.
How were Kromek Group PLC’s earnings last quarter?
Kromek Group PLC released its earnings results on Jan 20, 2026. The company reported 0.005 p earnings per share for the quarter, beating the consensus estimate of N/A by 0.005 p.
Is Kromek Group PLC overvalued?
According to Wall Street analysts Kromek Group PLC’s price is currently Overvalued.
Does Kromek Group PLC pay dividends?
Kromek Group PLC does not currently pay dividends.
What is Kromek Group PLC’s EPS estimate?
Kromek Group PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kromek Group PLC have?
Kromek Group PLC has 655,096,860 shares outstanding.
What happened to Kromek Group PLC’s price movement after its last earnings report?
Kromek Group PLC reported an EPS of 0.005 p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -9.565%.
Which hedge fund is a major shareholder of Kromek Group PLC?
Currently, no hedge funds are holding shares in GB:KMK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Kromek Group plc Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-7.19%
12-Months-Change
Fundamentals
Return on Equity
22.93%
Trailing 12-Months
Asset Growth
-1.64%
Trailing 12-Months
Company Description
Kromek Group PLC
Kromek Group plc (KMK) is a UK-based technology company that specializes in advanced radiation detection solutions. The company operates primarily in the sectors of security, medical imaging, and nuclear instrumentation. Kromek's core products include high-performance detectors and imaging systems that leverage its proprietary technology, particularly in the fields of gamma and X-ray detection. The company focuses on providing critical insights for applications such as airport security screening, medical diagnostics, and monitoring of nuclear facilities.
Technical Analysis
Gooch & Housego
―
Judges Scientific
―
TT Electronics
―
Windar Photonics
―
discoverIE Group plc
―
Options Prices
Currently, No data available
---